top of page

VENTURE CAPITAL

+

DATA SCIENCE

About

About Thomas

         VENTURE CAPITAL

  • Chief Technologist and Senior Advisor at Ducera Partners, a boutique investment bank with specialities including venture capital and private capital solutions, corporate restructuring, M&A, complex transactions and liability management. Since its founding in 2015, Ducera has exceeded $750 billion in deal volume.

  • Chief Technology Officer and Partner at WR Hambrecht+Co, where Thomas helps lead the firm's venture capital, asset management and technology innovation efforts. For more than 50 years WR Hambrecht+Co and its predecessor, Hambrecht & Quist, have provided early growth capital to more than 500 companies including Apple, Amazon and Google.

  • Founder of Growth Science Ventures, a venture capital firm that uses AI to identify early-stage disruptive startups. 

Venture Capital.png

           DATA SCIENCE

Thomas and his data science team built Quannix, an AI platform that provides unique insights into startups and other private businesses that disclose little or no public data about their financial or commercial status. Since 2008, Quannix has helped guide billions of dollars in venture capital, innovation, M&A and related growth initiatives.

 

Formerly, he used data science to guide growth investments at Intel and led a joint R&D effort at the Harvard Business School with Professor Clayton Christensen to develop quantitative predictive models for early stage innovation. He also helped found a business in the high performance computing industry that was acquired. 

Growing up in Honduras, Bolivia, India, Nepal and Indonesia, Thomas believes innovation decisions are a critical, but poorly understood, key to improving social wellbeing worldwide. 

Speaking
Testimonials

"The man who knows whether any start up will live or die."

 

Wired

(View article)

Media

In The Media

Read some of the articles here.

Academia

In Academia

Truebel & Thurston, Danger in the Valley of Death: how the transition from preclinical research to clinical trials can impact valuationsDrug Discovery Today

Thurston & Shih, Handheld Graphics Organization

 Harvard Business Publishing

 

Thurston & Shih, Intel NBI: Image Components Organization, Harvard Business Publishing

 

Thurston & Shih, Intel Corporation's New Business Initiatives (A), Harvard Business Publishing

 

Thurston & Shih, MXP Digital Media Processor
Harvard Business Publishing

 

Thurston & Shih, Radio-Frequency Identification

Harvard Business Publishing

 

Thurston & Shih, Intel NBI: Vivonic, Harvard Business Publishing

 

Thurston & Singh, Disrupting the Consultants: Could the Advisers use some Advice?, Thunderbird International Business Review 

 

Fox, Thurston & Zaheer, Revenue Capital & Disruptive Models: Venture Funding Tools for Developing Nations

Massachusetts Institute of Technology Entrepreneurship Review

 

Thurston, Disrupting Venture Capital

Thunderbird International Business Review 

Contact

Contact Thomas

Thanks! Message sent.

bottom of page